Government Extends Deadline For Pharma Industry Ethics Compliance
Date
7/26/2024 2:33:13 PM
(MENAFN- KNN India)
New Delhi, Jul 26 (KNN)
The central government has announced an extension for Pharmaceutical and medical device companies to submit mandatory self-declarations regarding ethical marketing practices.
The new deadline is set for July 31, 2024, giving industry executives additional time to comply with regulations aimed at curbing unethical Promotion of drugs and medical devices.
Under the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, top executives are required to file undertakings for the fiscal year 2025, assuring their adherence to ethical marketing standards.
This move is part of the government's efforts to maintain integrity within the healthcare sector.
The extension comes in response to requests from several companies that reported difficulties in meeting the original deadline.
Industry insiders suggest that this adjustment will provide relief to firms struggling with compliance, as failure to submit the required declarations could have resulted in governmental action.
The Department of Pharmaceuticals (DoP) oversees this initiative, which is designed to promote transparency and ethical conduct in the marketing of pharmaceutical products and medical devices.
The self-declaration process is a key component of the UCPMP 2024, reflecting the government's commitment to regulating industry practices.
This development underscores the ongoing dialogue between the government and the healthcare industry, as both parties work towards establishing a framework that ensures ethical marketing while supporting business operations.
(KNN Bureau)
MENAFN26072024000155011030ID1108486930
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.